1Momand J ,Jung D ,Wilczynski S,et al. The MDM2 gene amplification database. Nucleic Acids Res, 1998,26 (15) :3453-3459
2Kumble S, Omary MB, Carwright CA, et al. Src activation in malignant and premalignant epithelia of Barrett's esophagus.Gastroenterology, 1997,112 (2) :348-356
3Hahn SA, Schutte M, Hogue AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome ^18q^21.1 science,1996,271 ( 5247 ) :350
4Rioux Leclercq N, Turlin B, Sutherland F, et al. Analysis of ki-67 ,P53 and Bcl-2 expression in the dysplasia-carcinoma sequence of Barrett's esophagus. Oncol Rep, 1999,6 (4) :877-882
5Sarbia M, Bittinger F, Grabellus F, et al. Expression of Bax, a proapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. Int J Cancer, 1997,73(4):508-513
6Torzewski M, Sarbia M, Heep H, et al. Expression of Bcl-x,an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. Clin Cancer Res, 1998,4(3):577-583
7Van Lieshout EM, Roelofs HM, Dekker S, et al. Polymorphic expression of the glutathione S-transferases PI gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res, 1999,59(3):586-589
8Morita S, Yano M, Tsujinaka T, et al. Association between genetic polymorphism of glutathione S-transferases PI and N-acetyhransferase2 and susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer, 1998,79 (5) :517-520
9Nimura Y, Yokoyama S, Fujimori M, et al, Genotyping of the CYP1 A1 and GSTM1 genes in esophageal Carcinoma patients with special reference to smoking, Cancer, 1997,80(5) : 852-857
10Lin DX, Tang YM, Peng Q, et al. Susceptibiliby to esophageal cancer and genetic polymorphisms in glutamione Stransferases T1,P1,and M1 and cytochrome P450 2E1. Cancer Epidemiol Biomarkers Prey, 1998,7 ( 11 ) : 1013-1018
